Fundraising Fox

Syndevrx

Cambridge, US · Delaware corporation

Biotech

Founders & leadership

DN
David NeafusExecutive
JM
James Michael ShanahanExecutive
BJ
Bradley J CarverExecutive

Board

ET
Eric TookerBoard director
MC
Michael CliffordBoard director
RL
Richard LoveBoard director
CF
Charles FlynnBoard director

Reported raises · per SEC filings

Form D private placements

$77.7M disclosed across 6 rounds · 2012–2024

▶$6.5MraisedDec 2025 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bradley J CarverExecutive Officer, Director
  • David NeafusExecutive Officer
  • Charles FlynnDirector
  • Jeffrey WellesDirector
  • James Michael ShanahanExecutive Officer, Director
  • Michael CliffordDirector
Offering amount
$20M
Amount sold
$6.5M
Proceeds to insiders
$1.1M
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$29.4MraisedOct 2024 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles FlynnDirector
  • Eric TookerDirector
  • David NeafusExecutive Officer
  • James Michael ShanahanExecutive Officer, Director
  • Michael CliffordDirector
  • Bradley J CarverExecutive Officer, Director
Offering amount
$29.4M
Amount sold
$29.4M
First sale
Sep 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$23.2MraisedDec 2023 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David NeafusExecutive Officer
  • Charlie FlynnDirector
  • James Michael ShanahanExecutive Officer, Director
  • Michael CliffordDirector
  • Eric TookerDirector
  • Bradley J CarverExecutive Officer, Director
Offering amount
$30M
Amount sold
$23.2M
Sales commissions
$80K
Proceeds to insiders
$2.4M
Placement agents
Butler Capital Partners
First sale
Jan 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$850KraisedMar 2019 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric TookerDirector
  • Charlie FlynnDirector
  • Bradley J CarverExecutive Officer, Director
  • James Michael ShanahanExecutive Officer, Director
  • David NeafusExecutive Officer
Offering amount
$5M
Amount sold
$850K
Sales commissions
$25K
Proceeds to insiders
$452K
Placement agents
Growth Capital Services
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedNov 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bradley J CarverExecutive Officer, Director
  • James Michael ShanahanExecutive Officer, Director
  • Richard LoveDirector
  • Eric TookerDirector
  • David NeafusExecutive Officer
Offering amount
$2.5M
Amount sold
$1.5M
Sales commissions
$75K
Proceeds to insiders
$216K
Placement agents
AlphaSource Capital Securities, LLC, Growth Capital Services
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.3MraisedMar 2017 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard LoveDirector
  • Eric TookerDirector
  • Bradley J CarverExecutive Officer, Director
  • David NeafusExecutive Officer
  • James Michael ShanahanExecutive Officer, Director
Offering amount
$18M
Amount sold
$16.3M
Sales commissions
$325K
Proceeds to insiders
$216K
Placement agents
AlphaSource Capital Securities, LLC, Growth Capital Services
First sale
Oct 2012
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Syndevrx raised?
Syndevrx has disclosed $77.7M raised across 6 rounds.
Where is Syndevrx headquartered?
Syndevrx is headquartered in Cambridge, US.